Kintegral Advisory’s Zimmer Biomet ZBH Stock Holding History

Kintegral Advisory’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.02M	Buy	11,490 +64	+0.6%	+$6.06K	0.08%	174
2026 Q2	$986K	Hold	11,426	–	–	0.08%	175
2026 Q1	$1.04M	Sell	11,426 -507	-4%	-$46.5K	0.1%	167
2025 Q4	$1.08M	Sell	11,933 -327	-3%	-$31K	0.09%	167
2025 Q3	$1.21M	Sell	12,260 -55	-0.4%	-$5.45K	0.1%	164
2025 Q2	$1.13M	Sell	12,315 -18	-0.1%	-$1.74K	0.1%	171
2025 Q1	$1.4M	Sell	12,333 -42	-0.3%	-$4.49K	0.14%	148
2024 Q4	$1.31M	Sell	12,375 -576	-4%	-$61.8K	0.12%	159
2024 Q3	$1.4M	Sell	12,951 -170	-1%	-$18.6K	0.13%	153
2024 Q2	$1.43M	Buy	13,121 +1,407	+12%	+$166K	0.14%	151
2024 Q1	$1.55M	Sell	11,714 -37	-0.3%	-$4.62K	0.15%	131
2023 Q4	$1.43M	Buy	+11,751	New	+$1.31M	0.16%	136
2019 Q1	–	Sell	-2,104	Closed	-$212K	–	300
2018 Q4	$212K	Buy	+2,104	New	+$237K	0.06%	217

Other funds holding ZBH

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Northside Capital Management Hood River, Oregon $1.25B AUM 16.02% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Gilman Hill Asset Management New Canaan, Connecticut $718M AUM 15.3% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Kintegral Advisory's ZBH Position: Q3 2026 in Review

Kintegral Advisory increased its Zimmer Biomet (ZBH) stake by 0.56% in Q3 2026, buying an estimated $6.06K and bringing the position to 11,490 shares worth $1.02M. The position accounts for 0.08% of the portfolio, ranked #174.

Kintegral Advisory first reported a position in ZBH in Q4 2018 and has held it in 13 quarters since. The position peaked at $1.55M in Q1 2024. 132 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

Kintegral Advisory held 11,490 shares of Zimmer Biomet worth $1.02M as of Q3 2026.
Kintegral Advisory bought 64 Zimmer Biomet shares in Q3 2026, an estimated $6.06K.
Zimmer Biomet made up 0.08% of Kintegral Advisory's portfolio in Q3 2026, its #174 holding.
Kintegral Advisory first reported a position in Zimmer Biomet in Q4 2018 and has held it in 13 quarters since.
Kintegral Advisory's Zimmer Biomet position peaked at $1.55M in Q1 2024.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Kintegral Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.